ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Teikoku Pharma Announces Positive Results from Phase 2 Clinical Trial of TPU-006
August 24, 2017Teikoku Pharma announced positive topline results from its Phase 2 proof of concept study of TPU-006, a three-day dexmedetomidine transdermal patch, a novel drug delivery system with a non-opioid active moiety for the management of post-surgical pain.
Pharma Sources Insight January 2025
